Dynamic changes in tumor and blood T cells following neoadjuvant PD-L1 blockade & TGF-β neutralization in newly diagnosed head & neck cancers provide evidence that reversing tissue retention of T cells may enhance systemic anti-tumor immunity.
12.792 SRY0